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Background/Aims: Aging gastric mucosa is known to have 
decreased mucosal defenses and increased susceptibility 
to injury by nonsteroidal anti-inﬂ  ammatory drugs. Depending 
on the type of nonsteroidal anti-inﬂ  ammatory drug (NSAID), 
the underlying mechanisms and the extent of damage to the 
stomach or intestine may differ. This study was performed 
to evaluate the acute gastric damage caused by different 
doses of indomethacin, diclofenac and aspirin in rats of vari-
ous ages. Methods: For the acute models, indomethacin 
(10, 20 or 40 mg/kg), diclofenac (40 or 80 mg/kg) or aspirin 
(100 mg/kg) was given to 7- and 25-week-old and 1-year-old 
Sprague-Dawley rats by intragastric gavage. The gross ulcer 
index, damage area as assessed by imaging, histological in-
dex, myeloperoxidase (MPO) activity, and cytosolic phospho-
lipase A2 (cPLA2) levels were measured after 24 hours. Re-
sults: The gross ulcer index and damage area increased with 
age in the presence of three NSAIDs (p<0.05). The increases 
in MPO levels induced by diclofenac and aspirin were sig-
niﬁ  cantly higher in 1-year-old than 7-week-old rats (p<0.05). 
cPLA2 expression induced by indomethacin (10 and 40 mg/
kg) was greater in the 1-year-old rats, compared with 7-week-
old rats (p<0.05). Conclusions: NSAID-induced acute gastric 
damage increased in a dose- and age-dependent manner. 
(Gut Liver 2012;6:210-217)
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INTRODUCTION
Nonsteroidal anti-inflammatory drugs (NSAIDs) including 
aspirin are widely used as anti-inflammatory and analgesic 
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agents, and are commonly prescribed by physicians. However, 
gastrointestinal toxicity associated with NSAIDs is an important 
medical problem. Gastric mucosal injury is thought to result 
when aggressive luminal factors (such as acid, NSAIDs, or He-
licobacter pylori) overwhelm mucosal protective mechanism.
1,2 
Most previous studies examining gastric mucosal injury have 
investigated the mechanisms of NSAID-induced gastric mucosal 
lesions development and progression.
3,4 Although the inhibition 
of cyclooxygenase (COX) induced by NSAIDs leading to the 
depletion of endogenous prostaglandins is known to be a major 
pathogenic element in the development of these lesions, there 
are other factors including neutrophil activation,
5,6 decrease of 
gastric mucus production,
7,8 hypermotility,
9 and oxygen free 
radicals.
10 However, the exact pathogenic mechanism remains 
to be elucidated. Mucosal proinflammatory cytokines such as 
tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-8 
are considered to be key factors of gastric injury induced by 
NSAIDs like indomethacin.
11 In addition to proinflammatory cy-
tokines, the accumulation and activation of neutrophils, which 
may lead to microcirculation disturbances and the production 
of free radicals in gastric mucosa, are also important events in 
gastric injury due to NSAIDs.
12,13
While increased exposure to NSAIDs among the elderly is 
an obvious risk factor the development of NSAID gastropathy 
and its complications, epidemiologic analyses indicate that ag-
ing is an independent risk factor.
14 However, there are a few 
experimental data on age-related changes in gastric mucosal 
functions that may predispose the elderly to NSAID gastropa-
thy.
15-17 Experimental and limited clinical studies indicate that 
aging gastric mucosa has impaired mucosal defenses such as 
decreased mucus and bicarbonate secretion,
17-19 decreased pros-
taglandin generation,
15,20,21 reduced nitric oxide synthase activ-Seo PJ, et al: NSAID-Induced Gastric Damage according to Age in Rats  211
ity,
17,22 and reduced blood flow.
23,24 Furthermore, aging increases 
the susceptibility to injury by a variety of damaging agents such 
ethanol
7,23 as well as NSAIDs,
25,26 and also impairs the healing of 
acute injury and chronic gastric ulcers.
15,27
It has been reported that gastric toxicity is strongly influenced 
by the amount of drug dissolved under the pH conditions rather 
than the potency of the drug as an inhibitor of prostaglandin 
synthesis.
28 For example, aspirin exerts its gastrotoxic effects 
predominantly by localized action during the gastric absorp-
tion of the drug; aspirin is much more gastrotoxic than other 
NSAIDs despite its relatively low potency as a COX inhibitor.
28 
In contrast, indomethacin is associated with greater intestinal 
toxicity compared to other NSAIDs, suggesting that it could be 
related to enterohepatic circulation and the continuous inhibi-
tion of prostaglandins.
28 These results suggest that the extent 
of ulcer damage and the related mechanisms might be different 
depending on the type or dose of NSAID.
Based on these previous findings, we investigated the acute 
gastric damage caused by different dosages of three NSAIDs, 
indomethacin, diclofenac, and aspirin, in rats of various ages to 
provide information for understanding the mechanism underly-
ing acute NSAIDs-induced gastric damage.
MATERIALS AND METHODS
1. Animals
Six-, 24-, and 51-week-old male Sprague-Dawley (SD) rats 
were purchased (Orient Co., Ltd., Seoul, Korea) and housed in 
wire-bottom cages maintained at 20
oC to 26
oC, 35% to 75% 
humidity and in a 12/12-hour light/dark cycle (lights on, 8:00 
to 20:00) under pathogen-free conditions. After 1 week of ad-
aptation, 7-week-old (weighing 260 to 290 g), 25-week-old 
(weighting 600 to 800 g) and 1-year-old (weighting 600 to 850 g) 
rats were used for the experiments. All experimental procedures 
were approved by the Institutional Animal Care and Use Com-
mittee (IACUC) of Seoul National University Bundang Hospital.
2. Experimental design
The rats were starved but given water for 24 hours prior to 
the experiments. NSAIDs (indomethacin, Sigma-Aldrich Co., St. 
Louis, MO, USA, 10, 20 or 40 mg/kg body weight; diclofenac, 
Sigma-Aldrich Co., 40 or 80 mg/kg body weight; or aspirin, 
Sigma-Aldrich Co., 100 mg/kg body weight) or 0.5% carboxy-
methylcellulose (CMC; 5 mL/kg body weight) as a control were 
administered orally by gavage through a metal tube attached 
to a 5- or 10-mL syringe. Each group consisted of seven rats. 
The indomethacin solution was dissolved in 0.5% (wt/vol) CMC 
with 10% ethanol, pH ranging from 1.3 to 1.5. The aspirin solu-
tion was prepared in the same way but with 20% ethanol which 
maintained aspirin in its readily-absorbed non-ionized form. 
The diclofenac solution was dissolved in 0.5% (wt/vol) CMC. As 
we used 10% and 20% ethanol to dissolve indomethacin and 
aspirin, respectively, we tested these percentages on control rat 
to confirm that it was not a potential confounder. There was no 
specific lesion occurred with 20% ethanol similar to 0.5% CMC, 
and 0.5% CMC was administered into control group as a ve-
hicle. Twenty-four hours after NSAID or vehicle administration, 
the animals were humanely sacrificed and the gastric lesions 
were scored. 
3. Gross damage (gross ulcer index and damage area) and 
histological index
After sacrifice, the isolated stomachs were cut open along 
the greater curvature and washed in ice-cold saline. To inves-
tigate the degree of gross mucosal damage, the mucosal sides 
of the stomachs were photographed using a digital camera, 
and part of the mucosa was immediately fixed with a 10% 
formalin solution. The mucosal surface was macroscopically 
observed and ulcer scores were determined. The gross damage 
of the gastric mucosa was assessed by two experienced gas-
troenterologists, who were blinded to the experiment, using a 
previously described gross ulcer index
7,29 defined as (number of 
type I lesions)+(number of type II lesions)×2+(number of type II 
lesions)×3. The lesion type was classified as follows: type I indi-
cated the presence of edema, hyperemia, or a single submucosal 
punctiform hemorrhage; type II was defined as the presence 
of submucosal hemorrhagic lesions with small erosions; and 
type III indicated the presence of a deep ulcer with erosions and 
invasive lesions. A total injury score for each stomach was cal-
culated by summing the gross ulcer index of all lesions in that 
stomach. In addition, the damage area was also measured by 
the image program. The areas of gross damage (erosion or ul-
ceration) were measured by using a computerized video analysis 
system (MetaMorph 7.0; Molecular Devices, Downington, PA, 
USA). The area of mucosal damage was expressed as a percent-
age of the total mucosal area.
The stomach was cut longitudinally to a 5 mm width from 
the cardia to the pylorus in the anterior aspect after opening 
stomach along greater curvature regardless of the damaged area 
or inflammation, and fixed in the formalin. The tissue speci-
mens were dehydrated and embedded in paraffin. The longest 
part of the specimen was sectioned into 6 μm fragments, and 
the sections were stained with hematoxylin and eosin (H&E). 
An experienced pathologist who was blinded to the experiment 
examined all tissues. The mucosal damage was graded by as-
signing a previous described index of histological injury
30 de-
fined as (% type I damage)×1+(% type II damage)×2+(% type III 
damage)×3. The types of damage were defined as follows: type 
0 damage meant all gastric mucosal cells appeared intact and 
had a normal shape, location, appearance, and density; type I 
damage indicated that surface epithelial cells and the uppermost 
2 or 3 cells lining the glands were damaged; type II damage 
described damage greater than type I but involving <50% of the 
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damage involving >50% of the gastric mucosa depth.
4. Measurement of mucosal myeloperoxidase (MPO)
An assay of gastric mucosal MPO concentration was used to 
quantify the degree of neutrophil infiltration.
31,32 Three hundred 
milligrams of scraped mucosa were homogenized for 30 seconds 
with a polytron homogenizer in 1.0 mL of ice-cold 0.5% hexa-
decyltrimethylammonium bromide in 50 mM phosphate buffer 
(pH 6.0). Hexadecyltrimethylammonium bromide was used to 
negate the pseudoperoxidase activity of hemoglobin and to sol-
ubalize membrane-bound MPO. The homogenate was sonicated 
for 10 seconds, freeze-thawed three times and centrifuged for 
20 minutes at 18,000 ×g. The supernatant was isolated and the 
MPO concentration was determined using an ELISA kit (Im-
mundiagnostik AG, Bensheim, Germany).
5. Western blotting for cytosolic phospholipase A2 (cPLA2)
Gastric expression of cPLA2 was used to quantify the degree 
of inflammation. The gastric mucosa was homogenized with 
lysis buffer containing 25 mM Tris-HCL (pH 7.4), EGTA (1 mM), 
DTT (1 mM), leupeptin (10 μg/mL), aprotinin (10 μg/mL), PMSF 
(1 mM), and Triton X-100 (0.1%). The proteins (30 μg for each 
sample) were separated by SDS-PAGE (7.5% gel) and trans-
ferred to nitrocellulose membranes. All procedures were done in 
Tris buffer (40 mM, pH 7.55) containing 0.3 M NaCl and 0.3% 
Tween 20. The membranes were then blocked with 6% (wt/vol) 
milk and subsequently incubated with an anti-cPLA2 antibody 
(mouse monoclonal IgG2b antibody, 1:500 dilution; Santa Cruz 
Biotechnology, Santa Cruz, CA, USA) overnight at 4
oC. The blots 
were then incubated with a secondary antibody (goat polyclonal 
antibody, 1:5,000 dilution; Santa Cruz Biotechnology) and an 
imaging analyzer was used to measure the band densities.
6. Statistical analysis
All statistical calculations were performed using SPSS soft-
ware version 12.0 (SPSS Inc., Chicago, IL, USA). The results 
were compared using the Mann-Whitney U test and Kruskall-
Wallis test. All values are reported as the mean±standard error 
(SEM). Statistical significance was set at p<0.05. 
RESULTS
1. Gross ﬁ  ndings of indomethacin-, diclofenac- and aspirin-
induced damage
The gross appearance of gastric damage patterns was differ-
ent depending on the type of NSAIDs, and became more appar-
ent when the damage was severe (Fig. 1). Indomethacin caused 
a punctuate type clean ulcer, and was accompanied by hemor-
rhage when the damage was severe. The gastric damage induced 
by dicolfenac was similar to that caused by indomethacin, but 
the depth of ulcers was shallow and the damage extent was less 
severe than that caused by indomethacin (Fig. 1). In contrast, 
the ulcers caused by aspirin were usually shallow and had a 
linear shape, but were associated with hemorrhage more often 
than those caused by indomethacin or diclofenac (Fig. 1). 
Fig. 1. Gross findings of the gastric 
damage caused by indomethacin (10 
mg/kg), diclofenac (40 mg/kg), and 
aspirin (100 mg/kg) in rats. 
Indo, indomethacin; DF, diclofenac; 
Asp, aspirin.Seo PJ, et al: NSAID-Induced Gastric Damage according to Age in Rats  213
2. Gross ulcer index and damage area depending on age 
and dose of NSAIDs
All of the NSAID groups showed significantly higher gross 
ulcer index values than the control group (Fig. 2A). The gross 
ulcer index increased with aging in rat treated with all three 
kinds of NSAIDs (Fig. 2A). These were proportionally increased 
in animals treated with indomethacin (10, 20, or 40 mg/kg). 
That is, the gross ulcer index in a 1-year-old rat treated with in-
domethacin was significantly higher than that in a 7-week-old 
rat (p<0.05). However, the gross ulcer index of rats treated with 
diclofenac (40 and 80 mg/kg) as well as aspirin (100 mg/kg) 
were not significantly associated with age (Fig. 2A). The damage 
area measured by the image program was distinctly increased 
with aging in rats that received all three NSAID treatments (Fig. 
2B). All three kinds of NSAIDs significantly induced more se-
vere damage in 1-year-old rats than in 7-week-old rats. 
When the extent of the damage was assessed according to 
the dose of indomethacin, there was a statistically significant 
increase in the gross ulcer index as well as the area of dam-
age (Fig. 2) in the animals treated with 40 mg/kg indomethacin 
compared to ones that received 10 mg/kg regardless of age (7- 
and 25-week-old, or 1-year-old rats). With diclofenac, this dose-
dependent increase in the gross ulcer index was not observed 
but there was a significant difference in the area of damage (Fig. 
2). That is, the damage area was significantly increased by 80 
mg/kg diclofenac compared to 40 mg/kg diclofenac in 7-week- 
and 1-year-old rats.
3. Histological index depending on age
The histological index tended to increase with age in the rats 
treated with NSAIDs (Fig. 3). Gastric damage caused by indo-
methacin, diclofenac, or aspirin were more severe in 1-year-old 
rats than 7-week-old rats, but there was no statistical signifi-
cance (Fig. 3). In case of 7-week group of diclofenac 80 mg/kg 
and 25-week group in aspirin 100 mg/kg the histological index 
was near zero similar to control group.
4. MPO levels and expression of cPLA2 depending on age 
MPO levels were increased in the all of the NSAID-treated 
groups compared to the control group (Fig. 4A). When these 
levels were compared in each NSAID group according to age, 
the MPO levels in diclofenac or aspirin group were significantly 
higher in the 1-year-old rats than 7-week-old rats. In animals 
treated with indomethacin, the MPO levels were increased with 
age but there was no significant difference (Fig. 4A). cPLA2 ex-
pression in the rats treated with 10 and 40 mg/kg indomethacin 
was higher in 1-year-old rats than 7-week-old rats (Fig. 4B). 
However, there was no significant difference in groups treated 
Fig. 2. (A) Gross ulcer index and (B) damaged area in the rat stomachs (7- and 25-week-old and 1-year-old rats) assessed by the image program. 
Mean±standard error with seven rats per group. 
Indo10, indomethacin 10 mg/kg; Indo20, indomethacin 20 mg/kg; Indo40, indomethacin 40 mg/kg; DF40, diclofenac 40 mg/kg; DF80, diclofenac 
80 mg/kg; Asp 100, aspirin 100 mg/kg. 
*p<0.05 compared with the 7-week-old rats in the same nonsteroidal anti-inflammatory drug-treatment group.
Fig. 3. Histological index in the rat stomachs (7- and 25-week-old 
and 1-year-old rats). Mean±standard error with seven rats per group. 
Indo10, indomethacin 10 mg/kg; Indo20, indomethacin 20 mg/kg; 
Indo40, indomethacin 40 mg/kg; DF40, diclofenac 40 mg/kg; DF80, 
diclofenac 80 mg/kg; Asp 100, aspirin 100 mg/kg. 214  Gut and Liver, Vol. 6, No. 2, April 2012
with the other two NSAIDs (Fig. 4B).
DISCUSSION
Although the mechanisms of NSAID-induced gastric injury 
are not well understood, it is widely accepted that both COX-
dependent and -independent mechanisms are involved. Fur-
thermore, various factors such as the stimulation of gastric acid 
production, inflammatory cells infiltration, cytokines, mucosal 
blood flow, and free radicals are known to contribute to the de-
velopment of NSAID-induced gastric mucosal damage. We pre-
viously suggested that the impairment of apoptosis, angiogene-
sis, and sensory neuron activity via the activation of early gross 
response-1 (Egr-1), phosphatase and tension homologue deleted 
on chromosome 10 (PTEN) might increase the susceptibility 
of the gastric mucosa to injury with aging using 6-, 30-, and 
74-week-old and 2-year-old Fischer 344 rats.
17 However, since 
the Fischer 344 rat, the well-known rat strain for the aging or 
the carcinogenicity, are not appropriate for the acute or chronic 
NSAID-induced inflammation experiment (not published), we 
decided to use SD rat in our present study, which was the com-
monly used rat strain in the previously published papers regard-
ing NSAID-induced enteropathy. When we determined the gross 
damage caused by the different types or doses of NSAIDs using 
the gross ulcer index, the damage was found to be more severe 
in 1-year-old rats than 7-week-old rats. Furthermore, this age-
related tendency became clearer when the damage area was 
calculated by the image program instead of simply counting 
the number of ulcer or erosion. When we measured the area of 
NSAID-induced damage, there was a statistically significant dif-
ference between 7-week-old and 1-year-old rats treated with ei-
ther diclofenac (40, 80 mg/kg) or aspirin (100 mg/kg). However, 
when the damage was measured by the gross ulcer index, there 
was no statistical difference.
Both the gross ulcer index and the damage area increased in 
a dose-dependent manner by indomethacin. However, when 
the area of diclofenac-induced damage was compared between 
rats that received 40 or 80 mg/kg of the drug, there was a sig-
nificant difference only in the damage area but not in the gross 
ulcer index. These results may be explained by the fact that the 
gross ulcer index could not measure the severity of damage in 
the long- or wide-shaped lesions which were frequently found 
in the diclofenac- and aspirin-treated groups. Similar to our re-
sults, there was a report that both indomethacin and diclofenac 
administration increases gastric damage in a dose-dependent 
manner.
33
MPO concentration, a biochemical indicator of the degree 
of mucosal neutrophil infiltration, increases with the develop-
ment of gastric mucosal injury. MPO levels have been shown 
to increase concomitantly with gastric injury in indomethacin-
treated rats.
34 With age, the capacity of the stomach lining to 
resist damage decreases which in turn increases the risk of 
peptic ulcer disease, especially in people who use aspirin and 
other NSAIDs.
25 Several studies have reported an increased 
susceptibility of the gastric mucosa to various injuries in older 
animals.
15,24,35,36 In the present study, MPO levels of the 1-year-
old rats were significantly higher than those in the 7-week-old 
rats treated with diclofenac (40 and 80 mg/kg) or aspirin (100 
mg/kg). However, this trend was not found in the indomethacin 
group, suggesting that the impact of aging could be different 
depending on the type of NSAID. 
There are two pathways to metabolize the arachidonic acid 
released from membrane phospholipids to the chemical signal 
transmitter in the inflammation process. One of them is the 
prostagladins synthesis through COX and the other one is the 
leukotriene (leukotriene A4, B4, C4, D4, E4) synthesis through   
Fig. 4. Mucosal concentrations of (A) myeloperoxidase (MPO) and (B) cPLA2 expression in the rat stomachs (7- and 25-week-old and 1-year-old 
rats). Mean±standard error with seven rats per group. 
Indo10, indomethacin 10 mg/kg; Indo20, indomethacin 20 mg/kg; Indo40, indomethacin 40 mg/kg; DF40, diclofenac 40 mg/kg; DF80, diclofenac 
80 mg/kg; Asp100, aspirin 100 mg/kg. 
*p<0.05 compared with the 7-week-old rats in the same nonsteroidal anti-inflammatory drug-treatment group.Seo PJ, et al: NSAID-Induced Gastric Damage according to Age in Rats  215
5-LOX. LTB4, a by-product of 5-LOX and cPLA2, is the major 
chemotactic factor for leukocytes and has been reported to play 
an important pathophysiological role in the development of 
gastroduodenal ulcers.
37 Recently, we also reported a high in-
crease of cPLA2 and 5-LOX expression, and MPO mucosal levels 
after ethanol administration.
38 In contrast to this ethanol model, 
NSAID-treated rats did not show much difference in cPLA2 ex-
pression although it was higher in 1-year-old rats compared to 
the 7-week-old rats treated with indomethacin (10 and 40 mg/
kg). Furthermore, histological index, which was higher in the 
ethanol model,
38 showed a tendency to increase with age in the 
NSAID-treated animals in the present study, but there was no 
statistical significance. These results altogether suggest that the 
damage after exposure of NSAIDs for 24 hours might not be 
sustained through neutrophil infiltration. Neutrophil infiltration 
into the injured mucosa has been shown to occur as early as 
15 to 30 minutes after indomethacin administration in rats.
39 In 
addition, when mucosal damage and repair observed at 3 and 
24 hours after aspirin administration were compared, less dam-
age and higher regeneration was found at 24 hours than at 3 
hours.
16 Thus, mucosal damage at the 24 hour-incubation in the 
present study might have been sustained after direct damage 
by NSAIDs instead of cPLA2-neutrophil pathway. Furthermore, 
NSAIDs promote neutrophil-endothelial adhesive interactions, 
but not neutrophil migration into the extravascular space.
40,41 
This may explain why the gastric inflammation induced by 
NSAIDs is less extensive than that caused by either H. pylori
42 
or ethanol
43 in which gastric damage occurs through neutrophil 
migration. In addition, there was no statistical significance in 
the aspect of histological index in spite of statistical difference 
in the gross damage in the aged rat. This discrepancy could be 
explained by the different collection of data for gross and his-
tological damage index. That is, the gross damage was counted 
from the entire gastric mucosa before separation of stomach for 
histology and biochemistry. However, the tissue for histology 
was collected from certain area of stomach regardless of the 
damaged area or inflammation. Furthermore, the histological 
damage counting system is based on neutrophil infiltration in 
the mucosa that NSAID-induced mucosal damage is milder than 
ethanol-induced model similar to cPLA2 results.
Until now, there have been few studies which compared vari-
ous types of NSAID-induced gastric damage in animals. Zhang 
et al.
34 reported that intragastric gavaged indomethacin (48 mg/
kg) induced linear hemorrhagic lesions in the glandular mucosa. 
Takeuchi et al.
44 also reported that indomethacin administration 
led to either non-hemorrhagic or hemorrhagic gastric lesions 
which were linear or dotted. Diclofenac administered subcu-
taneously at dose of 40 mg/kg
45 or by intragastric gavage at 
50 mg/kg
46 caused hemorrhagic lesions. Intragastric gavage of 
aspirin (200 mg/kg) also produced linear and dotted erosion in 
the gastric mucosa.
6 When the three NSAIDS were compared in 
the present study, gross NSAID-induced gastric damage was dif-
ferent depending upon the type of NSAIDs. Both indomethacin 
and diclofenac caused linear-shaped ulcers with dented spots, 
but the damage caused by indomethacin-induced ulcers was 
more severe. In contrast, the ulcers caused by aspirin were rela-
tively shallow and linear-shaped, and were accompanied with 
hemorrhage more frequently than those caused by the other two 
NSAIDs. 
The present study has a limitation. That is, the age-dependent 
effect on NSAIDs-induced gastric damage and difference of gas-
tric damage depending on the type or dose of NSAID has been 
investigated in SD rat model. However, the underlying mecha-
nisms (such as COX/prostaglandin pathway, mucus production, 
microcirculation etc.) and difference in susceptibility among 
NSAIDs have not been evaluated in the present study. Further 
studies regarding the underlying detailed mechanisms and sus-
ceptibility among NSAIDs are planned in the future.
In summary, the gross gastric damage induced by indometha-
cin, diclofenac, or aspirin increased according to dosage and age 
in rats. However, the differences in gastric damage were greater 
when the damaged area was measured by the image program 
than by the gross ulcer index. Increases in MPO levels induced 
by diclofenac and aspirin were significantly higher in 1-year-
old rats compared to 7-week-old rats, and cPLA2 expression was 
higher in 1-year-old rats compared to 7-week-old rats among 
the animals treated with indomethacin and diclofenac. We also 
found that gross NSAID-induced gastric damage occurred in 
different patterns according to the type of NSAID. In conclu-
sion, NSAID-induced acute gastric damage increased in a dose- 
and age-dependent manner.
CONFLICTS OF INTEREST 
No potential conflict of interest relevant to this article was 
reported.
ACKNOWLEDGEMENTS
This work was supported by a grant (no. 06-2009-032) from 
the Seoul National University Bundang Hospital Research Fund.
REFERENCES
1. Allen A, Flemström G, Garner A, Kivilaakso E. Gastroduodenal 
mucosal protection. Physiol Rev 1993;73:823-857.
2. Flemstrom G, Garner A. Gastroduodenal HCO3(-) transport: char-
acteristics and proposed role in acidity regulation and mucosal 
protection. Am J Physiol 1982;242:G183-G193.
3. Beck PL, Xavier R, Lu N, et al. Mechanisms of NSAID-induced 
gastrointestinal injury defined using mutant mice. Gastroenterol-
ogy 2000;119:699-705.
4. Yoshikawa T, Naito Y, Kishi A, et al. Role of active oxygen, lipid 
peroxidation, and antioxidants in the pathogenesis of gastric mu-216  Gut and Liver, Vol. 6, No. 2, April 2012
cosal injury induced by indomethacin in rats. Gut 1993;34:732-
737.
5. Yoshida N, Yoshikawa T, Nakamura Y, et al. Role of neutrophil-
mediated inflammation in aspirin-induced gastric mucosal injury. 
Dig Dis Sci 1995;40:2300-2304.
6. Odashima M, Otaka M, Ohba R, et al. Attenuation of gastric mu-
cosal inflammation induced by aspirin through inhibition of selec-
tive type III phospshodiesterase in rats. Dig Dis Sci 2007;52:1355-
1359.
7. Nam SY, Kim N, Lee CS, et al. Gastric mucosal protection via en-
hancement of MUC5AC and MUC6 by geranylgeranylacetone. Dig 
Dis Sci 2005;50:2110-2120.
8. Corfield AP, Carroll D, Myerscough N, Probert CS. Mucins in 
the gastrointestinal tract in health and disease. Front Biosci 
2001;6:D1321-D1357.
9.  Takeuchi K, Tanaka A, Hayashi Y, Kubo Y. Functional mechanism 
underlying COX-2 expression following administration of indo-
methacin in rat stomachs: importance of gastric hypermotility. Dig 
Dis Sci 2004;49:180-187.
10. Del Soldato P, Foschi D, Benoni G, Scarpignato C. Oxygen free 
radicals interact with indomethacin to cause gastrointestinal in-
jury. Agents Actions 1986;17:484-488.
11.  Okada A, Kinoshita Y, Waki S, et al. Rat gastric mucosal cells ex-
press ICAM-1 and proinflammatory cytokines during indometha-
cin-induced mucosal injury. J Lab Clin Med 1998;131:538-547.
12. Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced 
by nonsteroidal anti-inflammatory drugs is a neutrophil-depen-
dent process. Am J Physiol 1990;259(3 Pt 1):G462-G467.
13.  Wallace JL. Nonsteroidal anti-inflammatory drugs and gas-
troenteropathy: the second hundred years. Gastroenterology 
1997;112:1000-1016.
14. Lee M. Prevention and treatment of nonsteroidal anti-inflamma-
tory drug-induced gastropathy. South Med J 1995;88:507-513.
15.  Lee M, Feldman M. Age-related reductions in gastric mucosal 
prostaglandin levels increase susceptibility to aspirin-induced in-
jury in rats. Gastroenterology 1994;107:1746-1750.
16. Lee M, Hardman WE, Cameron I. Age-related changes in gastric 
mucosal repair and proliferative activities in rats exposed acutely 
to aspirin. Gerontology 1998;44:198-203.
17.  Kang JM, Kim N, Kim JH, et al. Effect of aging on gastric 
mucosal defense mechanisms: ROS, apoptosis, angiogenesis, 
and sensory neurons. Am J Physiol Gastrointest Liver Physiol 
2010;299:G1147-G1153.
18.  Kim SW, Parekh D, Townsend CM Jr, Thompson JC. Effects of ag-
ing on duodenal bicarbonate secretion. Ann Surg 1990;212:332-
337.
19. Hinsull SM. Effect of colloidal bismuth subcitrate on age related 
gastric lesions in the rat. Gut 1991;32:355-360.
20. Vogiagis D, Glare EM, Misajon A, Brown W, O’Brien PE. Cyclo-
oxygenase-1 and an alternatively spliced mRNA in the rat stom-
ach: effects of aging and ulcers. Am J Physiol Gastrointest Liver 
Physiol 2000;278:G820-G827.
21.  Cryer B, Redfern JS, Goldschmiedt M, Lee E, Feldman M. Effect of 
aging on gastric and duodenal mucosal prostaglandin concentra-
tions in humans. Gastroenterology 1992;102(4 Pt 1):1118-1123.
22.  Grønbech JE, Lacy ER. Role of gastric blood flow in impaired de-
fense and repair of aged rat stomachs. Am J Physiol 1995;269(5 
Pt 1):G737-G744.
23.  Tarnawski A, Pai R, Deng X, et al. Aging gastropathy-novel mech-
anisms: hypoxia, up-regulation of multifunctional phosphatase 
PTEN, and proapoptotic factors. Gastroenterology 2007;133:1938-
1947.
24.  Goto H, Tachi K, Hisanaga Y, et al. Exacerbatory mechanism 
responsible for water immersion stress-induced gastric lesions in 
aged rats compared with young rats. Clin Exp Pharmacol Physiol 
2001;28:659-662.
25. Lee M, Feldman M. The aging stomach: implications for NSAID 
gastropathy. Gut 1997;41:425-426.
26.  Singh G. Recent considerations in nonsteroidal anti-inflammatory 
drug gastropathy. Am J Med 1998;105(1B):31S-38S.
27. Tsukimi Y, Okabe S. Changes in gastric function and healing of 
chronic gastric ulcers in aged rats. Jpn J Pharmacol 1995;68:103-
110.
28.  Beck WS, Schneider HT, Dietzel K, Nuernberg B, Brune K. Gastro-
intestinal ulcerations induced by anti-inflammatory drugs in rats. 
Physicochemical and biochemical factors involved. Arch Toxicol 
1990;64:210-217.
29.  Pandit S, Sur TK, Jana U, Bhattacharyya D, Debnath PK. Anti-ul-
cer effect of Shankha bhasma in rats: a preliminary study. Indian 
J Pharmacol 2000;32:378-380.
30.  Lacy ER, Ito S. Microscopic analysis of ethanol damage to rat gas-
tric mucosa after treatment with a prostaglandin. Gastroenterology 
1982;83:619-625.
31.  Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measure-
ment of cutaneous inflammation: estimation of neutrophil content 
with an enzyme marker. J Invest Dermatol 1982;78:206-209.
32.  Grisham MB, Benoit JN, Granger DN. Assessment of leukocyte in-
volvement during ischemia and reperfusion of intestine. Methods 
Enzymol 1990;186:729-742.
33.  Kim JH, Rhee HI, Jung IH, et al. SKI306X, an oriental herbal mix-
ture, suppresses gastric leukotriene B4 synthesis without causing 
mucosal injury and the diclofenac-induced gastric lesions. Life Sci 
2005;77:1181-1193.
34.  Zhang X, Tajima K, Kageyama K, Kyoi T. Irsogladine maleate 
suppresses indomethacin-induced elevation of proinflamma-
tory cytokines and gastric injury in rats. World J Gastroenterol 
2008;14:4784-4790.
35.  Uchida M, Kawano O, Misaki N, Saitoh K, Irino O. Healing of 
acetic acid-induced gastric ulcer and gastric mucosal PGI2 level in 
rats. Dig Dis Sci 1990;35:80-85.
36. Atchison CR, Balakumaran A, West AB, Hoffmann WE, Treinen-
Moslen M. Aging enhances susceptibility of diclofenac-treated rats 
to gastric ulceration, while attenuating enteropathy. Dig Dis Sci 
2000;45:614-620.Seo PJ, et al: NSAID-Induced Gastric Damage according to Age in Rats  217
37.  Gambero A, Maróstica M, Becker TL, Pedrazzoli J Jr. Effect of dif-
ferent cyclooxygenase inhibitors on gastric adaptive cytoprotec-
tion induced by 20% ethanol. Dig Dis Sci 2007;52:425-433.
38.  Kang JM, Kim N, Kim B, et al. Gastroprotective action of Co-
chinchina momordica seed extract is mediated by activation of 
CGRP and inhibition of cPLA(2)/5-LOX pathway. Dig Dis Sci 
2009;54:2549-2560.
39.  Anthony A, Sim R, Dhillon AP, Pounder RE, Wakefield AJ. Gastric 
mucosal contraction and vascular injury induced by indomethacin 
precede neutrophil infiltration in the rat. Gut 1996;39:363-368.
40. Yoshida N, Yoshikawa T. Effect of Helicobacter pylori-mediated 
inflammation on nonsteroidal anti-inflammatory drugs-induced 
gastric mucosal injury. Keio J Med 2002;51 Suppl 2:45-50.
41. Asako H, Kubes P, Wallace J, Gaginella T, Wolf RE, Granger DN. 
Indomethacin-induced leukocyte adhesion in mesenteric ve-
nules: role of lipoxygenase products. Am J Physiol 1992;262(5 Pt 
1):G903-G908.
42. Yoshida N, Granger DN, Evans DJ Jr, et al. Mechanisms involved 
in Helicobacter pylori-induced inflammation. Gastroenterology 
1993;105:1431-1440.
43.  Kvietys PR, Twohig B, Danzell J, Specian RD. Ethanol-induced 
injury to the rat gastric mucosa. Role of neutrophils and xanthine 
oxidase-derived radicals. Gastroenterology 1990;98:909-920.
44.  Takeuchi K, Ueki S, Okabe S. Importance of gastric motility in the 
pathogenesis of indomethacin-induced gastric lesions in rats. Dig 
Dis Sci 1986;31:1114-1122.
45.  Komoike Y, Takeeda M, Tanaka A, Kato S, Takeuchi K. Prevention 
by parenteral aspirin of indomethacin-induced gastric lesions in 
rats: mediation by salicylic acid. Dig Dis Sci 2002;47:1538-1545.
46.  Sánchez S, Martín MJ, Ortiz P, Motilva V, Alarcón de la Lastra 
C. Effects of dipyrone on inflammatory infiltration and oxidative 
metabolism in gastric mucosa: comparison with acetaminophen 
and diclofenac. Dig Dis Sci 2002;47:1389-1398.